# A Single-arm Safety Study of Transplantation Using Umbilical Cord Blood and Human Placental-derived Stem Cells From Partially Matched Related Donors in Persons With Certain Malignant Blood Diseases and Non-malignant Disorders

> **NCT00596999** · — · UNKNOWN · sponsor: **Celgene Corporation** · enrollment: 6 (estimated)

## Conditions studied

- Hematologic Malignancies

## Interventions

- **PROCEDURE:** UCB and HPDSC

## Key facts

- **NCT ID:** NCT00596999
- **Lead sponsor:** Celgene Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2007-05
- **Primary completion:** 2013-07
- **Final completion:** 2013-12
- **Target enrollment:** 6 (ESTIMATED)
- **Last updated:** 2012-04-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00596999

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00596999, "A Single-arm Safety Study of Transplantation Using Umbilical Cord Blood and Human Placental-derived Stem Cells From Partially Matched Related Donors in Persons With Certain Malignant Blood Diseases and Non-malignant Disorders". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00596999. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*